Correction: The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy-Response

Clin Cancer Res. 2016 Nov 15;22(22):5619. doi: 10.1158/1078-0432.CCR-16-1542.
No abstract available

Publication types

  • Published Erratum